Trial intelligence / Profile preview

Decoding Pain Sensitivity in Migraine

NCT04702971Phase 4Recruiting

Sponsor
Taipei Veterans General Hospital
Start
Feb 2021
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of flunarizine in migraine, sponsored by Taipei Veterans General Hospital. Started Feb 2021; status: recruiting.

02

Drugs

flunarizine
03

Conditions

migraine

Beyond the preview

Go deeper on NCT04702971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04702971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call